Last updated on May 2018

Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML


Brief description of study

The purpose of the study is to determine whether Fludarabine in combination with cytarabine is more effective than high-dose cytarabine in post-remission therapy for patients with core-binding factor acute myeloid leukemia

Clinical Study Identifier: NCT02926586

Contact Investigators or Research Sites near you

Start Over

Xianmin Song, Doctor

Xianmin Song
Shanghai, China
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.